Bracco Diagnostics
http://www.bracco.com

Related Content

HLT Inc., a Bracco Group Company and a leader in the development of cutting edge transcatheter aortic valve replacement (TAVR) therapy, announced today that it has received U.S. Food and Drug Administration (FDA) approval for two clinical studies to assess the performance and safety of its HLT Meridian TAVR Valve System to treat aortic stenosis and aortic regurgitation among high-risk patients suffering from aortic disease.
News | Structural Heart
HLT, Inc. Gains FDA Approval for Two TAVR Clinical Studies

March 24, 2022 — HLT Inc., a Bracco Group Company and a leader in the development of cutting edge transcatheter aortic ...

Home March 24, 2022
arrow
The HLT, Bracco, Meridian II TAVR Valve System.
Feature | Structural Heart| Dave Fornell, Editor
Bracco Moving Forward With HLT Meridian TAVR Valve

June 2, 2021 — The startup company HLT is a part of the Bracco Group, which is developing a new transcatheter aortic ...

Home June 02, 2021
arrow
The individuals who appear are for illustrative purposes only. All persons depicted are models and not real patients or healthcare professionals.
Case Study | Cardiovascular Ultrasound
Pass-Through Status and New Procedure Codes Are a Boon for Contrast-Enhanced Ultrasound Procedures

As part of the Consolidated Appropriations Act of 2018, pass-through payment status for LUMASON® (sulfur hexafluoride ...

Home May 29, 2019
arrow
European Medicines Agency Issues Update on Gadolinium Contrast Agents
News | Contrast Media
European Medicines Agency Issues Update on Gadolinium Contrast Agents

August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of ...

Home August 29, 2017
arrow
Bayer Arterion contrast media Injector used to administer medical imaging contrast for CT scans.
Feature | Contrast Media| Dave Fornell
Recent Developments and Issues in Contrast Media

Here are several updates in medical imaging contrast media agents. Two of the biggest news items were related to safety ...

Home June 19, 2017
arrow
News | Contrast Media
Global Contrast Media Market to Surpass $6 Billion by 2022

April 13, 2016 — The global market for contrast media is set to rise from just over $4.3 billion in 2015 to over $6 ...

Home April 13, 2016
arrow
Lumason, CMS, ultrasound contrast agent, approval for reimbursement, Bracco
News | Contrast Media
Echocardiography Contrast Agent Approved for Medicare Reimbursement

October 21, 2015 — Bracco Diagnostics Inc. announced that Lumason was approved by the Centers for Medicare and Medicaid ...

Home October 21, 2015
arrow
Bracco, Lumason, first U.S. echocardiography procedure, Morristown
Feature
First U.S. Lumason Echocardiography Imaging Procedure Performed

June 4, 2015 - Bracco Imaging announced that the first echocardiography imaging procedure with Lumason was performed in ...

Home June 04, 2015
arrow
Technology
Bracco Launches EmpowerCTA+ Contrast Injection System

March 6, 2015 — Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its ...

Home March 06, 2015
arrow
Radiation dose monitoring software analytics offered by Sectra.
Feature | Radiation Dose Management| Dave Fornell
Software to Help Manage Medical Imaging Radiation Dose

Cardiac imaging accounts for about one-third of the source of X-ray radiation dose for all medical imaging. Expanding ...

Home February 18, 2015
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now